Key result
This review highlights the urgent need for antiviral therapies against human parechoviruses, which are increasingly recognized as causes of sepsis-like illness and CNS infections in young children.
Highlights the emerging clinical significance of human parechoviruses in pediatric sepsis and CNS infections, and reviews potential antiviral treatment strategies.
Authors
No takes yet. Share an insight, caveat, or question.
Should not yet change pediatric HPeV management; leaves open antiviral development and trial validation.
Wildenbeest et al. (2010) conducted a review in Human parechovirus (HPeV) infections. Antiviral therapy was evaluated. This review highlights the urgent need for antiviral therapies against human parechoviruses, which are increasingly recognized as causes of sepsis-like illness and CNS infections in young children.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: